Winogut Sachet contains Saccharomyces boulardii 282.5 mg, a non-pathogenic yeast probiotic used to restore and maintain healthy intestinal flora. It is indicated for the prevention and treatment of various types of diarrhea, including antibiotic-associated diarrhea, acute infectious diarrhea, and traveler’s diarrhea. Saccharomyces boulardii exerts its therapeutic effects by inhibiting the growth of pathogenic bacteria, modulating the immune response, and enhancing the intestinal barrier function. This probiotic is also beneficial in managing irritable bowel syndrome (IBS) symptoms and preventing Clostridium difficile-associated diarrhea. Winogut Sachet is administered orally, with the contents dissolved in water or other suitable fluids. It is generally well tolerated, with minimal adverse effects reported, primarily mild gastrointestinal discomfort in rare cases. Use is contraindicated in patients with known hypersensitivity to Saccharomyces boulardii or any component of the formulation. Caution is advised in immunocompromised individuals due to the potential risk of fungemia. The product is suitable for adults and children, with dosing adjusted according to clinical indication and patient age. Winogut Sachet should be stored in a cool, dry place, protected from moisture and direct sunlight to preserve probiotic viability.